These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 588416)
1. Interaction of ICRF 159 with radiation, and its effect on sub-lethal and potentially lethal radiation damage in vitro. Taylor IW; Bleehen NM Br J Cancer; 1977 Oct; 36(4):493-500. PubMed ID: 588416 [TBL] [Abstract][Full Text] [Related]
2. Changes in sensitivity to radiation and ICRF 159 during the life of monolayer cultures of EMT6 tumour line. Taylor IW; Bleehen NM Br J Cancer; 1977 May; 35(5):587-94. PubMed ID: 861147 [TBL] [Abstract][Full Text] [Related]
3. Radiation survival properties of cultured human gastric adenocarcinoma cells and the effect of AT-1727. He SQ; Li CF; Zhen XY; Zhou J; Liu TF Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):361-8. PubMed ID: 2921140 [TBL] [Abstract][Full Text] [Related]
4. Biological properties of ICRF-159 and related bis(dioxopiperazine) compounds. Herman EH; Witiak DT; Hellmann K; Waravdekar VS Adv Pharmacol Chemother; 1982; 19():249-90. PubMed ID: 6819768 [No Abstract] [Full Text] [Related]
5. Interaction of razoxane and radiation on cultured Chinese hamster cells. Kimler BF Int J Radiat Oncol Biol Phys; 1982 Aug; 8(8):1333-8. PubMed ID: 7141912 [TBL] [Abstract][Full Text] [Related]
6. Interaction of radiation and AT 1727 in HeLa S-3 cells in culture. He SQ; Kim SH; Kim JH Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1137-42. PubMed ID: 3997596 [TBL] [Abstract][Full Text] [Related]
7. ICRF-159 enhancement of radiation response in combined modality therapies. II. Differential responses of tumour and normal tissues. Kovacs CJ; Evans MJ; Burholt DR; Schenken LL Br J Cancer; 1979 May; 39(5):524-30. PubMed ID: 486308 [TBL] [Abstract][Full Text] [Related]
8. Reduction by ICRF-187 of acute daunorubicin toxicity in Syrian golden hamsters. Herman EH; El-Hage AN; Ferrans VJ; Witiak DT Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):217-31. PubMed ID: 6410471 [TBL] [Abstract][Full Text] [Related]
9. The cytokinetic and cytotoxic effects of ICRF-159 and ICRF-187 in vitro and ICRF-187 in human bone marrow in vivo. Wheeler RH; Clauw DJ; Natale RB; Ruddon RW Invest New Drugs; 1983; 1(4):283-95. PubMed ID: 6432722 [TBL] [Abstract][Full Text] [Related]
10. Effects of the L isomer (+)-1,2-bis(3,5-dioxopiperazine-1-yl)propane on cell survival and cell cycle progression of cultured mammalian cells. Traganos F; Darzynkiewicz Z; Melamed MR Cancer Res; 1981 Nov; 41(11 Pt 1):4566-76. PubMed ID: 6171341 [TBL] [Abstract][Full Text] [Related]
11. ICRF 159-induced cell-cycle perturbation in vitro: its relationship to inhibition of colony-forming ability. Edgar DH; Creighton AM Br J Cancer; 1981 Aug; 44(2):236-40. PubMed ID: 7023524 [TBL] [Abstract][Full Text] [Related]
12. ICRF-159 enhancement of radiation response in combined modality therapies. I. Time/dose relationships for tumour response. Kovacs CJ; Evans MJ; Schenken LL; Burholt DR Br J Cancer; 1979 May; 39(5):516-23. PubMed ID: 486307 [TBL] [Abstract][Full Text] [Related]
13. Effect of ICRF-187 on doxorubicin-induced myocardial effects in the mouse and guinea pig. Perkins WE; Schroeder RL; Carrano RA; Imondi AR Br J Cancer; 1982 Oct; 46(4):662-7. PubMed ID: 6814473 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of radiosensitization by halogenated pyrimidines: effect of BrdU on cell killing and interphase chromosome breakage in radiation-sensitive cells. Iliakis G; Pantelias G; Kurtzman S Radiat Res; 1991 Jan; 125(1):56-64. PubMed ID: 1986401 [TBL] [Abstract][Full Text] [Related]
15. Influence of a 1400-gauss magnetic field on the radiosensitivity and recovery of EMT6 cells in vitro. Rockwell S Int J Radiat Biol Relat Stud Phys Chem Med; 1977 Feb; 31(2):153-60. PubMed ID: 300719 [TBL] [Abstract][Full Text] [Related]
16. Effect of stereoisomers related to ICRF-159 on metastasis of B16 melanoma. Zwilling BS; Campolito LB; Reiches NA; George T; Witiak DT Br J Cancer; 1981 Oct; 44(4):578-83. PubMed ID: 7295515 [TBL] [Abstract][Full Text] [Related]
17. Potentiation of doxorubicin cytotoxicity by (+)-1,2-bis-(3,5-dioxopiperazinyl-1-yl) propane (ICRF-187) in human leukemic HL-60 cells. Monti E; Sinha BK Cancer Commun; 1990; 2(4):145-9. PubMed ID: 2164412 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the protective effect of ICRF-187 and structurally related analogues against acute daunorubicin toxicity in Syrian golden hamsters. Herman EH; el-Hage AN; Creighton AM; Witiak DT; Ferrans VJ Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):39-55. PubMed ID: 3922023 [TBL] [Abstract][Full Text] [Related]
19. Effect of pretreatment with ICRF-187 on the total cumulative dose of doxorubicin tolerated by beagle dogs. Herman EH; Ferrans VJ; Young RS; Hamlin RL Cancer Res; 1988 Dec; 48(23):6918-25. PubMed ID: 3141049 [TBL] [Abstract][Full Text] [Related]
20. Inheritance of cellular resistance to the antitumor agent ICRF 159 in somatic cell hybrids. Edgar DH; Creighton AM J Natl Cancer Inst; 1982 Jun; 68(6):977-80. PubMed ID: 6953277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]